5-Hydroxytryptophan
The therapeutic efficacy of Oxitriptan can be increased when used in combination with Isocarboxazid.
Acarbose
Isocarboxazid may increase the hypoglycemic activities of Acarbose.
Acebutolol
Isocarboxazid may increase the hypotensive activities of Acebutolol.
Advertisement
Acepromazine
The therapeutic efficacy of Acepromazine can be increased when used in combination with Isocarboxazid.
Aceprometazine
The therapeutic efficacy of Aceprometazine can be increased when used in combination with Isocarboxazid.
Acetophenazine
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Acetophenazine.
Advertisement
Albiglutide
Isocarboxazid may increase the hypoglycemic activities of Albiglutide.
Albuterol
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Salbutamol.
Aldesleukin
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Aldesleukin.
Advertisement
Alfentanil
Isocarboxazid may increase the central nervous system depressant (CNS depressant) and hypertensive activities of Alfentanil.
Aliskiren
Isocarboxazid may increase the hypotensive activities of Aliskiren.
Almotriptan
The serum concentration of Almotriptan can be increased when it is combined with Isocarboxazid.
Alogliptin
Isocarboxazid may increase the hypoglycemic activities of Alogliptin.
Alphaprodine
The risk or severity of adverse effects can be increased when Alphaprodine is combined with Isocarboxazid.
Alprazolam
The therapeutic efficacy of Alprazolam can be increased when used in combination with Isocarboxazid.
Alprenolol
Isocarboxazid may increase the hypotensive activities of Alprenolol.
Altretamine
Altretamine may increase the orthostatic hypotensive activities of Isocarboxazid.
Ambrisentan
Isocarboxazid may increase the hypotensive activities of Ambrisentan.
Amifostine
The risk or severity of adverse effects can be increased when Amifostine is combined with Isocarboxazid.
Amifostine Anhydrous
The risk or severity of adverse effects can be increased when Amifostine is combined with Isocarboxazid.
Amiloride
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Amiloride.
Amineptin
The therapeutic efficacy of Amineptine can be increased when used in combination with Isocarboxazid.
Amiodarone
The risk or severity of adverse effects can be increased when Amiodarone is combined with Isocarboxazid.
Amisulpride
The therapeutic efficacy of Amisulpride can be increased when used in combination with Isocarboxazid.
Amitriptyline
The therapeutic efficacy of Amitriptyline can be increased when used in combination with Isocarboxazid.
Amlodipine
Isocarboxazid may increase the hypotensive activities of Amlodipine.
Amobarbital
Amobarbital may increase the hypotensive activities of Isocarboxazid.
Amoxapine
The therapeutic efficacy of Amoxapine can be increased when used in combination with Isocarboxazid.
Amphetamine
Isocarboxazid may increase the hypertensive activities of Amphetamine.
Amphotericin B
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Isocarboxazid.
amphotericin B liposomal
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Isocarboxazid.
Amyl Nitrite
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Amyl Nitrite.
Aniracetam
The therapeutic efficacy of Aniracetam can be increased when used in combination with Isocarboxazid.
Apomorphine
The metabolism of Apomorphine can be decreased when combined with Isocarboxazid.
Apraclonidine
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Apraclonidine.
Arbutamine
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Arbutamine.
Arformoterol
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Arformoterol.
Aripiprazole
The therapeutic efficacy of Aripiprazole can be increased when used in combination with Isocarboxazid.
Arsenic Trioxide
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Isocarboxazid.
Asenapine
The therapeutic efficacy of Asenapine can be increased when used in combination with Isocarboxazid.
Atenolol
Isocarboxazid may increase the hypotensive activities of Atenolol.
Atomoxetine
Isocarboxazid may increase the central neurotoxic activities of Atomoxetine.
Atropine
Isocarboxazid may increase the hypertensive activities of Atropine.
Azilsartan
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Azilsartan medoxomil.
Azilsartan kamedoxomil
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Azilsartan medoxomil.
Azilsartan Medoxomil
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Azilsartan medoxomil.
Bambuterol
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Bambuterol.
Barbexaclone
Barbexaclone may increase the hypotensive activities of Isocarboxazid.
Barbital
Barbital may increase the hypotensive activities of Isocarboxazid.
Benactyzine
The therapeutic efficacy of Benactyzine can be increased when used in combination with Isocarboxazid.
Benazepril
Isocarboxazid may increase the hypotensive activities of Benazepril.
Bendroflumethiazide
Isocarboxazid may increase the hypotensive activities of Bendroflumethiazide.
Benperidol
The therapeutic efficacy of Benperidol can be increased when used in combination with Isocarboxazid.
Benzphetamine
Isocarboxazid may increase the hypertensive activities of Benzphetamine.
Bepridil
Isocarboxazid may increase the hypotensive activities of Bepridil.
BETAHISTINE
The serum concentration of Betahistine can be increased when it is combined with Isocarboxazid.
Betaxolol
Isocarboxazid may increase the hypotensive activities of Betaxolol.
Bethanidine
Isocarboxazid may increase the hypotensive activities of Bethanidine.
Bezafibrate
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Bezafibrate.
Bimatoprost
Isocarboxazid may increase the hypotensive activities of Bimatoprost.
Bisoprolol
Isocarboxazid may increase the hypotensive activities of Bisoprolol.
Bortezomib
The risk or severity of adverse effects can be increased when Bortezomib is combined with Isocarboxazid.
Bosentan
Isocarboxazid may increase the hypotensive activities of Bosentan.
Bretylium
Isocarboxazid may increase the hypotensive activities of Bretylium.
Brexpiprazole
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Brexpiprazole.
Brimonidine
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Brimonidine.
Bromazepam
The therapeutic efficacy of Bromazepam can be increased when used in combination with Isocarboxazid.
Bromocriptine
The metabolism of Bromocriptine can be decreased when combined with Isocarboxazid.
Bromperidol
The therapeutic efficacy of Bromperidol can be increased when used in combination with Isocarboxazid.
Bumetanide
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Bumetanide.
Bupivacaine
The risk or severity of adverse effects can be increased when Bupivacaine is combined with Isocarboxazid.
Bupranolol
Isocarboxazid may increase the hypotensive activities of Bupranolol.
Buprenorphine
The risk or severity of adverse effects can be increased when Buprenorphine is combined with Isocarboxazid.
Bupropion
The therapeutic efficacy of Bupropion can be increased when used in combination with Isocarboxazid.
Buspirone
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Buspirone.
Butorphanol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Isocarboxazid.
Cabergoline
The risk or severity of adverse effects can be increased when Cabergoline is combined with Isocarboxazid.
Cafedrine
Isocarboxazid may increase the hypotensive activities of Cafedrine.
Canagliflozin
Isocarboxazid may increase the hypoglycemic activities of Canagliflozin.
Canagliflozin Anhydrous
Isocarboxazid may increase the hypoglycemic activities of Canagliflozin.
Candesartan
Isocarboxazid may increase the hypotensive activities of Candesartan.
Candesartan Cilexetil
Isocarboxazid may increase the hypotensive activities of Candesartan cilexetil.
Captopril
Isocarboxazid may increase the hypotensive activities of Captopril.
Carbamazepine
The therapeutic efficacy of Carbamazepine can be increased when used in combination with Isocarboxazid.
Cariprazine
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Cariprazine.
Carteolol
Isocarboxazid may increase the hypotensive activities of Carteolol.
Carvedilol
Isocarboxazid may increase the hypotensive activities of Carvedilol.
Celiprolol
Isocarboxazid may increase the hypotensive activities of Celiprolol.
Chlordiazepoxide
The therapeutic efficacy of Chlordiazepoxide can be increased when used in combination with Isocarboxazid.
Chlormezanone
The therapeutic efficacy of Chlormezanone can be increased when used in combination with Isocarboxazid.
Chlorothiazide
Isocarboxazid may increase the hypotensive activities of Chlorothiazide.
Chlorpromazine
The therapeutic efficacy of Chlorpromazine can be increased when used in combination with Isocarboxazid.
Chlorpropamide
Isocarboxazid may increase the hypoglycemic activities of Chlorpropamide.
Chlorprothixene
The therapeutic efficacy of Chlorprothixene can be increased when used in combination with Isocarboxazid.
Chlorthalidone
Isocarboxazid may increase the hypotensive activities of Chlorthalidone.
Cicletanine
Isocarboxazid may increase the hypotensive activities of Cicletanine.
Cilazapril
Isocarboxazid may increase the hypotensive activities of Cilazapril.
Citalopram
The therapeutic efficacy of Citalopram can be increased when used in combination with Isocarboxazid.
Clemastine
Isocarboxazid may increase the anticholinergic activities of Clemastine.
Clenbuterol
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Clenbuterol.
Clevidipine
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Clevidipine.
Clevidipine butyrate
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Clevidipine.
Clofarabine
The risk or severity of adverse effects can be increased when Clofarabine is combined with Isocarboxazid.
Clomipramine
The therapeutic efficacy of Clomipramine can be increased when used in combination with Isocarboxazid.
Clonidine
Isocarboxazid may increase the hypotensive activities of Clonidine.
Clorazepate
The therapeutic efficacy of Clorazepate can be increased when used in combination with Isocarboxazid.
CLORAZEPIC ACID
The therapeutic efficacy of Clorazepate can be increased when used in combination with Isocarboxazid.
Clozapine
The therapeutic efficacy of Clozapine can be increased when used in combination with Isocarboxazid.
Codeine
The risk or severity of adverse effects can be increased when Codeine is combined with Isocarboxazid.
Codeine Anhydrous
The risk or severity of adverse effects can be increased when Codeine is combined with Isocarboxazid.
CODEINE POLISTIREX
The risk or severity of adverse effects can be increased when Codeine is combined with Isocarboxazid.
Conivaptan
The risk or severity of adverse effects can be increased when Conivaptan is combined with Isocarboxazid.
Cryptenamine
Isocarboxazid may increase the hypotensive activities of Cryptenamine.
Cyamemazine
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Cyamemazine.
Cyclobenzaprine
The therapeutic efficacy of Cyclobenzaprine can be increased when used in combination with Isocarboxazid.
Cyclopenthiazide
Isocarboxazid may increase the hypotensive activities of Cyclopenthiazide.
Cyclothiazide
Isocarboxazid may increase the hypotensive activities of Cyclothiazide.
Cyproheptadine
Isocarboxazid may increase the anticholinergic activities of Cyproheptadine.
Dapagliflozin
Isocarboxazid may increase the hypoglycemic activities of Dapagliflozin.
Dapiprazole
The therapeutic efficacy of Dapiprazole can be increased when used in combination with Isocarboxazid.
Deanol
The therapeutic efficacy of Deanol can be increased when used in combination with Isocarboxazid.
Debrisoquin
Isocarboxazid may increase the hypotensive activities of Debrisoquin.
Deserpidine
Isocarboxazid may increase the hypotensive activities of Deserpidine.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Isocarboxazid.
Desipramine
The therapeutic efficacy of Desipramine can be increased when used in combination with Isocarboxazid.
Desvenlafaxine
The therapeutic efficacy of Desvenlafaxine can be increased when used in combination with Isocarboxazid.
Deutetrabenazine
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Deutetrabenazine.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Dexmedetomidine.
Dexmethylphenidate
Isocarboxazid may increase the hypertensive activities of Dexmethylphenidate.
Dextroamphetamine
Isocarboxazid may increase the hypertensive activities of Dextroamphetamine.
Dextromethorphan
Isocarboxazid may increase the serotonergic activities of Dextromethorphan.
Dextromoramide
The risk or severity of adverse effects can be increased when Dextromoramide is combined with Isocarboxazid.
Dezocine
The risk or severity of adverse effects can be increased when Dezocine is combined with Isocarboxazid.
Diazepam
The therapeutic efficacy of Diazepam can be increased when used in combination with Isocarboxazid.
Diazoxide
Isocarboxazid may increase the hypotensive activities of Diazoxide.
Dichlorphenamide
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Diclofenamide.
Diethylpropion
Isocarboxazid may increase the hypertensive activities of Diethylpropion.
Dihydralazine
Isocarboxazid may increase the hypotensive activities of Dihydralazine.
Dihydrocodeine
The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Isocarboxazid.
Dihydroergotamine
The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Isocarboxazid.
Diltiazem
Isocarboxazid may increase the hypotensive activities of Diltiazem.
Dinutuximab
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Dinutuximab.
Diphenoxylate
The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Isocarboxazid.
Dipivefrin
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Dipivefrin.
Dipyridamole
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Dipyridamole.
Disopyramide
Isocarboxazid may increase the hypoglycemic activities of Disopyramide.
Disulfiram
The risk or severity of convulsion can be increased when Isocarboxazid is combined with Disulfiram.
Dobutamine
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Dobutamine.
Dolasetron
Dolasetron may increase the serotonergic activities of Isocarboxazid.
Domperidone
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Domperidone.
Dorzolamide
Isocarboxazid may increase the hypotensive activities of Dorzolamide.
Dothiepin
The therapeutic efficacy of Dosulepin can be increased when used in combination with Isocarboxazid.
Doxapram
Isocarboxazid may increase the hypertensive activities of Doxapram.
Doxazosin
Isocarboxazid may increase the hypotensive activities of Doxazosin.
Doxepin
The therapeutic efficacy of Doxepin can be increased when used in combination with Isocarboxazid.
Doxylamine
Isocarboxazid may increase the anticholinergic activities of Doxylamine.
Droperidol
The therapeutic efficacy of Droperidol can be increased when used in combination with Isocarboxazid.
Droxidopa
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Droxidopa.
Dulaglutide
Isocarboxazid may increase the hypoglycemic activities of Dulaglutide.
Duloxetine
The therapeutic efficacy of Duloxetine can be increased when used in combination with Isocarboxazid.
Eletriptan
The serum concentration of Eletriptan can be increased when it is combined with Isocarboxazid.
Empagliflozin
Isocarboxazid may increase the hypoglycemic activities of Empagliflozin.
Enalapril
Isocarboxazid may increase the hypotensive activities of Enalapril.
Enalaprilat
Isocarboxazid may increase the hypotensive activities of Enalaprilat.
Enalaprilat Anhydrous
Isocarboxazid may increase the hypotensive activities of Enalaprilat.
Entacapone
The risk or severity of adverse effects can be increased when Entacapone is combined with Isocarboxazid.
Epinephrine
Isocarboxazid may increase the hypertensive activities of Epinephrine.
Eplerenone
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Eplerenone.
Epoprostenol
Isocarboxazid may increase the hypotensive activities of Epoprostenol.
Eprosartan
Isocarboxazid may increase the hypotensive activities of Eprosartan.
ergoloid mesylates, USP
The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Isocarboxazid.
Ergonovine
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Ergonovine.
Ergotamine
Isocarboxazid may increase the hypertensive activities of Ergotamine.
Escitalopram
The therapeutic efficacy of Escitalopram can be increased when used in combination with Isocarboxazid.
Esmolol
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Esmolol.
Estazolam
The therapeutic efficacy of Estazolam can be increased when used in combination with Isocarboxazid.
Ethacrynate
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Etacrynic acid.
Ethacrynic Acid
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Etacrynic acid.
Ethanol
The risk or severity of adverse effects can be increased when Ethanol is combined with Isocarboxazid.
Ethyl Loflazepate
The therapeutic efficacy of Ethyl loflazepate can be increased when used in combination with Isocarboxazid.
Ethylmorphine
The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Isocarboxazid.
Etifoxine
The therapeutic efficacy of Etifoxine can be increased when used in combination with Isocarboxazid.
Exenatide
Isocarboxazid may increase the hypoglycemic activities of Exenatide.
Felodipine
Isocarboxazid may increase the hypotensive activities of Felodipine.
Fenfluramine
Isocarboxazid may increase the serotonergic activities of Fenfluramine.
Fenoldopam
Isocarboxazid may increase the hypotensive activities of Fenoldopam.
Fenoterol
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Fenoterol.
Fentanyl
The risk or severity of adverse effects can be increased when Fentanyl is combined with Isocarboxazid.
Ferulic Acid
Isocarboxazid may increase the hypotensive activities of Ferulic acid.
Flunitrazepam
The therapeutic efficacy of Flunitrazepam can be increased when used in combination with Isocarboxazid.
Fluoxetine
The therapeutic efficacy of Fluoxetine can be increased when used in combination with Isocarboxazid.
Flupenthixol
The therapeutic efficacy of Flupentixol can be increased when used in combination with Isocarboxazid.
Fluphenazine
The therapeutic efficacy of Fluphenazine can be increased when used in combination with Isocarboxazid.
Flurazepam
The therapeutic efficacy of Flurazepam can be increased when used in combination with Isocarboxazid.
Fluspirilene
The therapeutic efficacy of Fluspirilene can be increased when used in combination with Isocarboxazid.
Fluvoxamine
The therapeutic efficacy of Fluvoxamine can be increased when used in combination with Isocarboxazid.
Formoterol
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Formoterol.
Fosinopril
Isocarboxazid may increase the hypotensive activities of Fosinopril.
Frovatriptan
The serum concentration of Frovatriptan can be increased when it is combined with Isocarboxazid.
Furazolidone
Isocarboxazid may increase the hypertensive activities of Furazolidone.
Furosemide
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Furosemide.
Gabapentin
The therapeutic efficacy of Gabapentin can be increased when used in combination with Isocarboxazid.
Gliclazide
Isocarboxazid may increase the hypoglycemic activities of Gliclazide.
Glimepiride
Isocarboxazid may increase the hypoglycemic activities of Glimepiride.
Glipizide
Isocarboxazid may increase the hypoglycemic activities of Glipizide.
Glyburide
Isocarboxazid may increase the hypoglycemic activities of Glyburide.
Granisetron
Granisetron may increase the serotonergic activities of Isocarboxazid.
Guanabenz
Isocarboxazid may increase the hypotensive activities of Guanabenz.
Guanadrel
Isocarboxazid may increase the hypotensive activities of Guanadrel.
Guanethidine
Isocarboxazid may increase the hypotensive activities of Guanethidine.
Guanfacine
Isocarboxazid may increase the hypotensive activities of Guanfacine.
Halazepam
The therapeutic efficacy of Halazepam can be increased when used in combination with Isocarboxazid.
Haloperidol
The therapeutic efficacy of Haloperidol can be increased when used in combination with Isocarboxazid.
Halothane
The risk or severity of adverse effects can be increased when Halothane is combined with Isocarboxazid.
Heroin
The risk or severity of adverse effects can be increased when Heroin is combined with Isocarboxazid.
Hexobarbital
Hexobarbital may increase the hypotensive activities of Isocarboxazid.
Hydralazine
Isocarboxazid may increase the hypotensive activities of Hydralazine.
Hydrochlorothiazide
Isocarboxazid may increase the hypotensive activities of Hydrochlorothiazide.
Hydrocodone
The risk or severity of adverse effects can be increased when Hydrocodone is combined with Isocarboxazid.
HYDROCODONE POLISTIREX
The risk or severity of adverse effects can be increased when Hydrocodone is combined with Isocarboxazid.
Hydroflumethiazide
Isocarboxazid may increase the hypotensive activities of Hydroflumethiazide.
Hydromorphone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Isocarboxazid.
Hypericin
The therapeutic efficacy of Hypericin can be increased when used in combination with Isocarboxazid.
Iloperidone
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Iloperidone.
Iloprost
The risk or severity of adverse effects can be increased when Iloprost is combined with Isocarboxazid.
Imidapril
The risk or severity of adverse effects can be increased when Imidapril is combined with Isocarboxazid.
Imipramine
The therapeutic efficacy of Imipramine can be increased when used in combination with Isocarboxazid.
Indacaterol
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Indacaterol.
Indapamide
Isocarboxazid may increase the hypotensive activities of Indapamide.
Indoramin
Isocarboxazid may increase the hypotensive activities of Indoramin.
Insulin Detemir
Isocarboxazid may increase the hypoglycemic activities of Insulin Detemir.
Insulin Glargine
Isocarboxazid may increase the hypoglycemic activities of Insulin Glargine.
insulin human, rDNA origin
Isocarboxazid may increase the hypoglycemic activities of Insulin Human.
Insulin Lispro
Isocarboxazid may increase the hypoglycemic activities of Insulin Lispro.
Insulin, Aspart Protamine, Human
Isocarboxazid may increase the hypoglycemic activities of Insulin Aspart.
Insulin, Aspart, Human
Isocarboxazid may increase the hypoglycemic activities of Insulin Aspart.
Insulin, Glulisine, Human
Isocarboxazid may increase the hypoglycemic activities of Insulin Glulisine.
Insulin, Protamine Lispro, Human
Isocarboxazid may increase the hypoglycemic activities of Insulin Lispro.
Iproniazid
The therapeutic efficacy of Iproniazid can be increased when used in combination with Isocarboxazid.
Irbesartan
Isocarboxazid may increase the hypotensive activities of Irbesartan.
Isoetharine
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Isoetarine.
Isoflurane
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Isoflurane.
Isometheptene
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Isometheptene.
Isoproterenol
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Isoprenaline.
Isosorbide Dinitrate
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Isosorbide Dinitrate.
Isosorbide Mononitrate
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Isosorbide Mononitrate.
Isoxsuprine
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Isoxsuprine.
Isradipine
Isocarboxazid may increase the hypotensive activities of Isradipine.
Ketanserin
Isocarboxazid may increase the hypotensive activities of Ketanserin.
Ketazolam
The therapeutic efficacy of Ketazolam can be increased when used in combination with Isocarboxazid.
Labetalol
Isocarboxazid may increase the hypotensive activities of Labetalol.
Lacidipine
Isocarboxazid may increase the hypotensive activities of Lacidipine.
Latanoprost
Isocarboxazid may increase the hypotensive activities of Latanoprost.
Lercanidipine
Isocarboxazid may increase the hypotensive activities of Lercanidipine.
Levalbuterol
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Levosalbutamol.
Levobunolol
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Levobunolol.
Levobupivacaine
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Levobupivacaine.
Levodopa
The risk or severity of adverse effects can be increased when Levodopa is combined with Isocarboxazid.
Levomethadyl
The risk or severity of adverse effects can be increased when Levomethadyl Acetate is combined with Isocarboxazid.
Levomilnacipran
The therapeutic efficacy of Levomilnacipran can be increased when used in combination with Isocarboxazid.
Levonordefrin
Isocarboxazid may increase the hypertensive activities of Levonordefrin.
Levorphanol
The risk or severity of adverse effects can be increased when Levorphanol is combined with Isocarboxazid.
Levosimendan
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Levosimendan.
Linezolid
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Linezolid.
Liraglutide
Isocarboxazid may increase the hypoglycemic activities of Liraglutide.
Lisdexamfetamine
Isocarboxazid may increase the hypertensive activities of Lisdexamfetamine.
Lisdexamfetamine Dimesylate
Isocarboxazid may increase the hypertensive activities of Lisdexamfetamine.
Lisinopril
Isocarboxazid may increase the hypotensive activities of Lisinopril.
Lisinopril Anhydrous
Isocarboxazid may increase the hypotensive activities of Lisinopril.
Lisuride
The metabolism of Lisuride can be decreased when combined with Isocarboxazid.
Lithium
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Lithium.
Lithium Cation
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Lithium.
Lofexidine
Isocarboxazid may increase the hypotensive activities of Lofexidine.
Lorazepam
The therapeutic efficacy of Lorazepam can be increased when used in combination with Isocarboxazid.
Lorcaserin
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Lorcaserin.
Losartan
Isocarboxazid may increase the hypotensive activities of Losartan.
Loxapine
The therapeutic efficacy of Loxapine can be increased when used in combination with Isocarboxazid.
Lurasidone
The therapeutic efficacy of Lurasidone can be increased when used in combination with Isocarboxazid.
Macitentan
Isocarboxazid may increase the hypotensive activities of Macitentan.
Manidipine
Isocarboxazid may increase the hypotensive activities of Manidipine.
Mannitol
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Mannitol.
Maprotiline
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Maprotiline.
Mecamylamine
Isocarboxazid may increase the hypotensive activities of Mecamylamine.
Mecasermin
Isocarboxazid may increase the hypoglycemic activities of Mecasermin.
Mecasermin Rinfabate
Isocarboxazid may increase the hypoglycemic activities of Mecasermin.
Meperidine
Isocarboxazid may increase the hypotensive and central nervous system depressant (CNS depressant) activities of Pethidine.
Mephentermine
Isocarboxazid may increase the hypertensive activities of Mephentermine.
Mephobarbital
Methylphenobarbital may increase the hypotensive activities of Isocarboxazid.
Mepirodipine
The risk or severity of adverse effects can be increased when Barnidipine is combined with Isocarboxazid.
Meprobamate
The therapeutic efficacy of Meprobamate can be increased when used in combination with Isocarboxazid.
Mequitazine
Isocarboxazid may increase the anticholinergic activities of Mequitazine.
Mesoridazine
The therapeutic efficacy of Mesoridazine can be increased when used in combination with Isocarboxazid.
Metaproterenol
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Orciprenaline.
Metaraminol
Isocarboxazid may increase the hypertensive activities of Metaraminol.
Metformin
Isocarboxazid may increase the hypoglycemic activities of Metformin.
Methadone
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Methadone.
Methadyl Acetate
The risk or severity of adverse effects can be increased when Methadyl Acetate is combined with Isocarboxazid.
Methamphetamine
Isocarboxazid may increase the hypertensive activities of Methamphetamine.
Methazolamide
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Methazolamide.
Methohexital
Methohexital may increase the hypotensive activities of Isocarboxazid.
Methotrimeprazine
The therapeutic efficacy of Methotrimeprazine can be increased when used in combination with Isocarboxazid.
Methoxamine
Isocarboxazid may increase the hypertensive activities of Methoxamine.
Methyclothiazide
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Methyclothiazide.
Methyldopa
The risk or severity of hypertension can be increased when Isocarboxazid is combined with Methyldopa.
METHYLDOPA ANHYDROUS
The risk or severity of hypertension can be increased when Isocarboxazid is combined with Methyldopa.
Methylene blue
Isocarboxazid may increase the serotonergic activities of Methylene blue.
Methylphenidate
Isocarboxazid may increase the hypertensive activities of Methylphenidate.
Metipranolol
Isocarboxazid may increase the hypotensive activities of Metipranolol.
Metoclopramide
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Metoclopramide.
Metolazone
Isocarboxazid may increase the hypotensive activities of Metolazone.
Metoprolol
Isocarboxazid may increase the hypotensive activities of Metoprolol.
Metylperon
The therapeutic efficacy of Melperone can be increased when used in combination with Isocarboxazid.
Metyrosine
Isocarboxazid may increase the hypotensive activities of Metyrosine.
Mianserin
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Mianserin.
Mibefradil
Isocarboxazid may increase the hypotensive activities of Mibefradil.
Midazolam
The therapeutic efficacy of Midazolam can be increased when used in combination with Isocarboxazid.
Midodrine
Isocarboxazid may increase the hypertensive activities of Midodrine.
Mifepristone
Isocarboxazid may increase the hypoglycemic activities of Mifepristone.
Miglitol
Isocarboxazid may increase the hypoglycemic activities of Miglitol.
Milnacipran
The therapeutic efficacy of Milnacipran can be increased when used in combination with Isocarboxazid.
Minaprine
The therapeutic efficacy of Minaprine can be increased when used in combination with Isocarboxazid.
Minoxidil
Isocarboxazid may increase the hypotensive activities of Minoxidil.
Mirtazapine
The therapeutic efficacy of Mirtazapine can be increased when used in combination with Isocarboxazid.
Moclobemide
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Moclobemide.
Moexipril
Isocarboxazid may increase the hypotensive activities of Moexipril.
Molindone
The therapeutic efficacy of Molindone can be increased when used in combination with Isocarboxazid.
Morphine
The therapeutic efficacy of Morphine can be increased when used in combination with Isocarboxazid.
Moxonidine
Isocarboxazid may increase the hypotensive activities of Moxonidine.
Nabilone
The therapeutic efficacy of Nabilone can be increased when used in combination with Isocarboxazid.
Nadolol
Isocarboxazid may increase the hypotensive activities of Nadolol.
Nalbuphine
The risk or severity of adverse effects can be increased when Nalbuphine is combined with Isocarboxazid.
Naratriptan
The serum concentration of Naratriptan can be increased when it is combined with Isocarboxazid.
Nateglinide
Isocarboxazid may increase the hypoglycemic activities of Nateglinide.
Nebivolol
Isocarboxazid may increase the hypotensive activities of Nebivolol.
Nefazodone
The therapeutic efficacy of Nefazodone can be increased when used in combination with Isocarboxazid.
Nesiritide
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Nesiritide.
Nialamide
The therapeutic efficacy of Nialamide can be increased when used in combination with Isocarboxazid.
Nicardipine
Isocarboxazid may increase the hypotensive activities of Nicardipine.
Nicorandil
Nicorandil may increase the hypotensive activities of Isocarboxazid.
Nifedipine
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Nifedipine.
Nilvadipine
Isocarboxazid may increase the hypotensive activities of Nilvadipine.
Nimodipine
Isocarboxazid may increase the hypotensive activities of Nimodipine.
Nisoldipine
Isocarboxazid may increase the hypotensive activities of Nisoldipine.
Nitrazepam
The therapeutic efficacy of Nitrazepam can be increased when used in combination with Isocarboxazid.
Nitrendipine
Isocarboxazid may increase the hypotensive activities of Nitrendipine.
Nitric Oxide
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Nitric Oxide.
Nitroglycerin
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Nitroglycerin.
Nitroprusside
Isocarboxazid may increase the hypotensive activities of Nitroprusside.
Norepinephrine
Isocarboxazid may increase the hypertensive activities of Norepinephrine.
Normethadone
The risk or severity of adverse effects can be increased when Normethadone is combined with Isocarboxazid.
Nortriptyline
The therapeutic efficacy of Nortriptyline can be increased when used in combination with Isocarboxazid.
Obinutuzumab
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Obinutuzumab.
Olanzapine
The therapeutic efficacy of Olanzapine can be increased when used in combination with Isocarboxazid.
Olmesartan
Isocarboxazid may increase the hypotensive activities of Olmesartan.
Olodaterol
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Olodaterol.
Ondansetron
The therapeutic efficacy of Ondansetron can be increased when used in combination with Isocarboxazid.
Opipramol
The therapeutic efficacy of Opipramol can be increased when used in combination with Isocarboxazid.
Opium
The risk or severity of adverse effects can be increased when Opium is combined with Isocarboxazid.
Oxazepam
The therapeutic efficacy of Oxazepam can be increased when used in combination with Isocarboxazid.
Oxprenolol
The therapeutic efficacy of Oxprenolol can be increased when used in combination with Isocarboxazid.
Oxycodone
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Oxycodone.
Oxymorphone
The risk or severity of adverse effects can be increased when Oxymorphone is combined with Isocarboxazid.
p-Hydroxyamphetamine
Isocarboxazid may increase the hypertensive activities of Hydroxyamphetamine.
Paclitaxel
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Paclitaxel.
Paliperidone
The therapeutic efficacy of Paliperidone can be increased when used in combination with Isocarboxazid.
Palonosetron
Palonosetron may increase the serotonergic activities of Isocarboxazid.
Papaverine
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Papaverine.
Paregoric
The therapeutic efficacy of Morphine can be increased when used in combination with Isocarboxazid.
Pargyline
Isocarboxazid may increase the hypertensive activities of Pargyline.
Paroxetine
The therapeutic efficacy of Paroxetine can be increased when used in combination with Isocarboxazid.
Penbutolol
Isocarboxazid may increase the hypotensive activities of Penbutolol.
Pentamidine
Isocarboxazid may increase the hypoglycemic activities of Pentamidine.
Pentazocine
The risk or severity of adverse effects can be increased when Pentazocine is combined with Isocarboxazid.
Pentobarbital
Pentobarbital may increase the hypotensive activities of Isocarboxazid.
Perazine
The therapeutic efficacy of Perazine can be increased when used in combination with Isocarboxazid.
Pergolide
The metabolism of Pergolide can be decreased when combined with Isocarboxazid.
Periciazine
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Propericiazine.
Perindopril
Isocarboxazid may increase the hypotensive activities of Perindopril.
Perphenazine
The therapeutic efficacy of Perphenazine can be increased when used in combination with Isocarboxazid.
Phenelzine
The therapeutic efficacy of Phenelzine can be increased when used in combination with Isocarboxazid.
Phenethylamine
The therapeutic efficacy of Phenethylamine can be increased when used in combination with Isocarboxazid.
Phenobarbital
Phenobarbital may increase the hypotensive activities of Isocarboxazid.
Phenoxybenzamine
Isocarboxazid may increase the hypotensive activities of Phenoxybenzamine.
Phentermine
Isocarboxazid may increase the hypertensive activities of Phentermine.
PHENTERMINE RESIN
Isocarboxazid may increase the hypertensive activities of Phentermine.
Phentolamine
Isocarboxazid may increase the hypotensive activities of Phentolamine.
Phentolamine Mesylate
Isocarboxazid may increase the hypotensive activities of Phentolamine.
Phenylephrine
Isocarboxazid may increase the hypertensive activities of Phenylephrine.
Phenylpropanolamine
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Phenylpropanolamine.
Pholcodine
Pholcodine may increase the serotonergic activities of Isocarboxazid.
Pimozide
The therapeutic efficacy of Pimozide can be increased when used in combination with Isocarboxazid.
Pinacidil
Isocarboxazid may increase the hypotensive activities of Pinacidil.
Pindolol
Isocarboxazid may increase the hypotensive activities of Pindolol.
Pioglitazone
Isocarboxazid may increase the hypoglycemic activities of Pioglitazone.
Pipamperone
The therapeutic efficacy of Pipamperone can be increased when used in combination with Isocarboxazid.
Pipothiazine
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Pipotiazine.
Pirbuterol
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Pirbuterol.
Pirinitramide
The risk or severity of adverse effects can be increased when Piritramide is combined with Isocarboxazid.
Pizotyline
Isocarboxazid may increase the anticholinergic activities of Pizotifen.
Polythiazide
Isocarboxazid may increase the hypotensive activities of Polythiazide.
Pramipexole
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Pramipexole.
Pramlintide
Isocarboxazid may increase the hypoglycemic activities of Pramlintide.
Prazepam
The therapeutic efficacy of Prazepam can be increased when used in combination with Isocarboxazid.
Prazosin
Isocarboxazid may increase the hypotensive activities of Prazosin.
Pregabalin
The therapeutic efficacy of Pregabalin can be increased when used in combination with Isocarboxazid.
Primidone
Primidone may increase the hypotensive activities of Isocarboxazid.
Procarbazine
Isocarboxazid may increase the hypertensive activities of Procarbazine.
Procaterol
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Procaterol.
Prochlorperazine
The therapeutic efficacy of Prochlorperazine can be increased when used in combination with Isocarboxazid.
Progabide
The therapeutic efficacy of Progabide can be increased when used in combination with Isocarboxazid.
Promazine
The therapeutic efficacy of Promazine can be increased when used in combination with Isocarboxazid.
Promethazine
The risk or severity of adverse effects can be increased when Promethazine is combined with Isocarboxazid.
Propofol
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Propofol.
Propoxyphene
The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Isocarboxazid.
Propranolol
Isocarboxazid may increase the hypotensive activities of Propranolol.
Prothipendyl
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Prothipendyl.
Protriptyline
The therapeutic efficacy of Protriptyline can be increased when used in combination with Isocarboxazid.
Pseudoephedrine
Isocarboxazid may increase the hypertensive activities of Pseudoephedrine.
Quetiapine
The therapeutic efficacy of Quetiapine can be increased when used in combination with Isocarboxazid.
Quetiapine fumarate
The therapeutic efficacy of Quetiapine can be increased when used in combination with Isocarboxazid.
Quinapril
Isocarboxazid may increase the hypotensive activities of Quinapril.
Quinine
Isocarboxazid may increase the hypoglycemic activities of Quinine.
Ramipril
Isocarboxazid may increase the hypotensive activities of Ramipril.
Rasagiline
Isocarboxazid may increase the hypertensive activities of Rasagiline.
Reboxetine
The therapeutic efficacy of Reboxetine can be increased when used in combination with Isocarboxazid.
Regular Insulin, Human
Isocarboxazid may increase the hypoglycemic activities of Insulin Human.
Remifentanil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Isocarboxazid.
Remoxipride
The therapeutic efficacy of Remoxipride can be increased when used in combination with Isocarboxazid.
Repaglinide
Isocarboxazid may increase the hypoglycemic activities of Repaglinide.
Rescinnamine
Isocarboxazid may increase the hypotensive activities of Rescinnamine.
Reserpine
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Reserpine.
Rilmenidine
Isocarboxazid may increase the hypotensive activities of Rilmenidine.
Riociguat
Isocarboxazid may increase the hypotensive activities of Riociguat.
Risperidone
The therapeutic efficacy of Risperidone can be increased when used in combination with Isocarboxazid.
Ritodrine
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Ritodrine.
Rizatriptan
The serum concentration of Rizatriptan can be increased when it is combined with Isocarboxazid.
Ropinirole
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Ropinirole.
Ropivacaine
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Ropivacaine.
Rosiglitazone
Isocarboxazid may increase the hypoglycemic activities of Rosiglitazone.
Rotigotine
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Rotigotine.
Sacubitril
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Sacubitril.
Salmeterol
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Salmeterol.
Saxagliptin
Isocarboxazid may increase the hypoglycemic activities of Saxagliptin.
Saxagliptin Anhydrous
Isocarboxazid may increase the hypoglycemic activities of Saxagliptin.
Secobarbital
Secobarbital may increase the hypotensive activities of Isocarboxazid.
Selegiline
Selegiline may increase the hypertensive activities of Isocarboxazid.
Selexipag
Isocarboxazid may increase the hypotensive activities of Selexipag.
Sertindole
The therapeutic efficacy of Sertindole can be increased when used in combination with Isocarboxazid.
Sertraline
The therapeutic efficacy of Sertraline can be increased when used in combination with Isocarboxazid.
Sevoflurane
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Sevoflurane.
Sibutramine
The therapeutic efficacy of Sibutramine can be increased when used in combination with Isocarboxazid.
Sitagliptin
Isocarboxazid may increase the hypoglycemic activities of Sitagliptin.
Sitagliptin Phosphate
Isocarboxazid may increase the hypoglycemic activities of Sitagliptin.
Sotalol
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Sotalol.
Spirapril
Isocarboxazid may increase the hypotensive activities of Spirapril.
Spironolactone
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Spironolactone.
Streptokinase
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Streptokinase.
Sufentanil
The risk or severity of adverse effects can be increased when Sufentanil is combined with Isocarboxazid.
Sulfadiazine
Isocarboxazid may increase the hypoglycemic activities of Sulfadiazine.
Sulfamethoxazole
Isocarboxazid may increase the hypoglycemic activities of Sulfamethoxazole.
Sulfisoxazole
Isocarboxazid may increase the hypoglycemic activities of Sulfisoxazole.
Sulpiride
The therapeutic efficacy of Sulpiride can be increased when used in combination with Isocarboxazid.
Sumatriptan
The serum concentration of Sumatriptan can be increased when it is combined with Isocarboxazid.
Sumatriptan Succinate
The serum concentration of Sumatriptan can be increased when it is combined with Isocarboxazid.
Sunitinib
Isocarboxazid may increase the hypoglycemic activities of Sunitinib.
Talinolol
Isocarboxazid may increase the hypotensive activities of Talinolol.
Tamsulosin
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Tamsulosin.
Tapentadol
The risk or severity of adverse effects can be increased when Tapentadol is combined with Isocarboxazid.
Tedizolid
Tedizolid Phosphate may increase the serotonergic activities of Isocarboxazid.
Tedizolid Phosphate
Tedizolid Phosphate may increase the serotonergic activities of Isocarboxazid.
Telmisartan
Isocarboxazid may increase the hypotensive activities of Telmisartan.
Temazepam
The therapeutic efficacy of Temazepam can be increased when used in combination with Isocarboxazid.
Terazosin
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Terazosin.
Terbutaline
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Terbutaline.
Terbutaline Sulfate
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Terbutaline.
Terlipressin
Isocarboxazid may increase the hypotensive activities of Terlipressin.
Testosterone Propionate
The risk or severity of adverse effects can be increased when Testosterone propionate is combined with Isocarboxazid.
Tetrabenazine
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Tetrabenazine.
Tetrahydrocannabinol
The therapeutic efficacy of Dronabinol can be increased when used in combination with Isocarboxazid.
Tetrahydrozoline
Isocarboxazid may increase the hypertensive activities of Tetryzoline.
Thalidomide
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Thalidomide.
Theodrenaline
Isocarboxazid may increase the hypotensive activities of Theodrenaline.
Thiamylal
Thiamylal may increase the hypotensive activities of Isocarboxazid.
Thiopental
Thiopental may increase the hypotensive activities of Isocarboxazid.
Thiopental Sodium
Thiopental may increase the hypotensive activities of Isocarboxazid.
Thioproperazine
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Thioproperazine.
Thioridazine
The therapeutic efficacy of Thioridazine can be increased when used in combination with Isocarboxazid.
Thiothixene
The therapeutic efficacy of Thiothixene can be increased when used in combination with Isocarboxazid.
Tianeptine
The risk or severity of adverse effects can be increased when Tianeptine is combined with Isocarboxazid.
Tiapride
The therapeutic efficacy of Tiapride can be increased when used in combination with Isocarboxazid.
Tibolone
Isocarboxazid may increase the hypotensive activities of Tibolone.
Timolol
Isocarboxazid may increase the hypotensive activities of Timolol.
Timolol Anhydrous
Isocarboxazid may increase the hypotensive activities of Timolol.
Tizanidine
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Tizanidine.
Tofisopam
The therapeutic efficacy of Tofisopam can be increased when used in combination with Isocarboxazid.
Tolazamide
Isocarboxazid may increase the hypoglycemic activities of Tolazamide.
Tolazoline
Isocarboxazid may increase the hypotensive activities of Tolazoline.
Tolbutamide
Isocarboxazid may increase the hypoglycemic activities of Tolbutamide.
Tolcapone
The risk or severity of adverse effects can be increased when Tolcapone is combined with Isocarboxazid.
Toloxatone
The therapeutic efficacy of Toloxatone can be increased when used in combination with Isocarboxazid.
Torsemide
Isocarboxazid may increase the hypotensive activities of Torasemide.
Tramadol
Tramadol may increase the neuroexcitatory activities of Isocarboxazid.
Trandolapril
Isocarboxazid may increase the hypotensive activities of Trandolapril.
Tranylcypromine
The therapeutic efficacy of Tranylcypromine can be increased when used in combination with Isocarboxazid.
Travoprost
Isocarboxazid may increase the hypotensive activities of Travoprost.
Trazodone
The therapeutic efficacy of Trazodone can be increased when used in combination with Isocarboxazid.
Treprostinil
Isocarboxazid may increase the hypotensive activities of Treprostinil.
Tretinoin
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Tretinoin.
Triamterene
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Triamterene.
Triazolam
The therapeutic efficacy of Triazolam can be increased when used in combination with Isocarboxazid.
Triazulenone
The therapeutic efficacy of Loprazolam can be increased when used in combination with Isocarboxazid.
Trichlormethiazide
Isocarboxazid may increase the hypotensive activities of Trichlormethiazide.
Trifluoperazine
The therapeutic efficacy of Trifluoperazine can be increased when used in combination with Isocarboxazid.
Triflupromazine
The therapeutic efficacy of Triflupromazine can be increased when used in combination with Isocarboxazid.
Trimethaphan
Isocarboxazid may increase the hypotensive activities of Trimethaphan.
Trimipramine
The therapeutic efficacy of Trimipramine can be increased when used in combination with Isocarboxazid.
Tropisetron
Tropisetron may increase the serotonergic activities of Isocarboxazid.
Tryptophan
L-Tryptophan may increase the serotonergic activities of Isocarboxazid.
UNOPROSTONE
Isocarboxazid may increase the hypotensive activities of Unoprostone.
Urapidil
Isocarboxazid may increase the hypotensive activities of Urapidil.
Valproate
The therapeutic efficacy of Valproic Acid can be increased when used in combination with Isocarboxazid.
Valproic Acid
The therapeutic efficacy of Valproic Acid can be increased when used in combination with Isocarboxazid.
Valsartan
Isocarboxazid may increase the hypotensive activities of Valsartan.
Vemurafenib
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Isocarboxazid.
Venlafaxine
The therapeutic efficacy of Venlafaxine can be increased when used in combination with Isocarboxazid.
Verapamil
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Verapamil.
Vilanterol
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Vilanterol.
Vilazodone
The therapeutic efficacy of Vilazodone can be increased when used in combination with Isocarboxazid.
Viloxazine
The therapeutic efficacy of Viloxazine can be increased when used in combination with Isocarboxazid.
Vincamine
Isocarboxazid may increase the hypotensive activities of Vincamine.
Vinpocetine
Isocarboxazid may increase the hypotensive activities of Vinpocetine.
Vortioxetine
The therapeutic efficacy of Vortioxetine can be increased when used in combination with Isocarboxazid.
Xylometazoline
Isocarboxazid may increase the hypotensive activities of Xylometazoline.
Ziprasidone
The therapeutic efficacy of Ziprasidone can be increased when used in combination with Isocarboxazid.
Zofenopril
Isocarboxazid may increase the hypotensive activities of Zofenopril.
Zolmitriptan
The serum concentration of Zolmitriptan can be increased when it is combined with Isocarboxazid.
Zotepine
The therapeutic efficacy of Zotepine can be increased when used in combination with Isocarboxazid.
Zuclopenthixol
The therapeutic efficacy of Zuclopenthixol can be increased when used in combination with Isocarboxazid.
